Skip to main content
Clinical Trials/NCT03458533
NCT03458533
Completed
Not Applicable

Changes in the Hypothalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity

University of Roma La Sapienza1 site in 1 country69 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight and Obesity
Sponsor
University of Roma La Sapienza
Enrollment
69
Locations
1
Primary Endpoint
Pituitary volume
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study aims to identify new morphological and quantitative magnetic imaging parameters of pituitary gland and sellar region in overweight and obese patient at baseline and after 3 years, dividing patients in 3 groups (weight loss through diet and lifestyle changes, weight loss through bariatric surgery, no weight loss)

Detailed Description

This longitudinal prospective study in overweight and obese patients aims to identify and characterize new morphological and quantitative MRI parameters of pituitary gland and sellar region assessed by texture analysis with a specific software (ImageJ©). These parameters will be correlated them to hypothalamic-pituitary-peripheral axis function, metabolism and body composition. Data will be detected at baseline and at 3 years follow-up to quantitatively identify the different pituitary MRI patterns in 3 groups: 1. patients without weight modifies 2. patients with weight loss obtain through diet and lifestyle changes 3. patients with weight loss obtained through bariatric surgery

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
June 30, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Roma La Sapienza
Responsible Party
Principal Investigator
Principal Investigator

Andrea M. Isidori

MD, PhD

University of Roma La Sapienza

Eligibility Criteria

Inclusion Criteria

  • BMI \> 25 Kg/m2

Exclusion Criteria

  • Malignant neoplasia;
  • Current use of psychotropic drugs;
  • Chronic renal failure;
  • Pituitary macroadenomas and craniopharyngiomas;
  • Contraindications to MRI execution (p. e. pace-maker, metal foreign bodies like slivers, non MRI compatible vascular clips or prosthesis)

Outcomes

Primary Outcomes

Pituitary volume

Time Frame: 0, +3 years

Change in pituitary volume (mm3) from baseline to 3 years

Secondary Outcomes

  • Evaluation of pituitary mean and standard deviation intensity(0, +3 years)
  • Correlation of magnetic resonance parameters with anthropometric measurements(0, +3 years)
  • Correlation of magnetic resonance parameters with pituitary axis function(0, +3 years)
  • Correlation of magnetic resonance parameters with glyco-metabolic status(0, +3 years)

Study Sites (1)

Loading locations...

Similar Trials